Loma Therapeutics
PrivateLast Round
Grant
Jun 1, 2026
Total Funding Raised
$3.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Loma Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Grant round in June 2025.
Loma Therapeutics is a biotechnology company developing a targeted viral-vector immunotherapy for HPV-induced cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Loma Therapeutics Comparables
Compare Loma Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BlueSky Immunotherapies GmbH | 82% | |
| NeoTrail Therapeutics, Inc. | 79% | |
| Nykode Therapeutics | 76% |
For institutional investors. Book with your work email.
Loma Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2026 | ||||
| Grant | Jun 26, 2025 | ||||
| Convertible Debt | Sep 1, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Accelerator | Sep 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Loma Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| European Commission | Grant |
| BioInnovation Institute | Convertible Debt, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
$724K grant from Innovation Fund Denmark
- Nov 12, 2025
Grew 38% QoQ, from 8 to 11 employees.
For institutional investors. Book with your work email.
Loma Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Loma Therapeutics's valuation, stock price, and market status.
Is Loma Therapeutics a public or private company?
Loma Therapeutics is a private company.
What is the current stock price of Loma Therapeutics?
Loma Therapeutics is a private company, so its shares have no public market price. Caplight tracks Loma Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Loma Therapeutics worth (valuation)?
Valuation information for Loma Therapeutics is not publicly available.
Can I buy Loma Therapeutics stock?
Loma Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Loma Therapeutics's last funding round?
Loma Therapeutics's most recent funding round was Grant on June 1, 2026.
Who are the main investors in Loma Therapeutics?
Key investors in Loma Therapeutics include Innovation Fund Denmark, European Commission, BioInnovation Institute.
Will Loma Therapeutics IPO soon?
No public IPO plans have been announced for Loma Therapeutics.
How can I track Loma Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Loma Therapeutics's shares on secondary markets.